Role of integrons, plasmids and SXT elements in multidrug resistance of Vibrio cholerae and Providencia vermicola obtained from a clinical isolate of diarrhea

Frontiers in Microbiology
Neha RajparaAshima Kushwaha Bhardwaj

Abstract

The isolates of Vibrio cholerae and Providencia vermicola obtained from a diarrheal patient were investigated for genetic elements governing their drug resistance phenotypes. Out of 14 antibiotics tested, V. cholerae Vc IDH02365 isolate showed resistance to nine antibiotics, while P. vermicola Pv NBA2365 was found to be resistant to all the antibiotics except polymyxin B. Though SXT integrase was depicted in both the bacteria, class 1 integron was found to be associated only with Pv NBA2365. Integrons in Pv NBA2365 conferred resistance to β-lactams, aminoglycosides, and trimethoprim. Pv NBA2365 carried two transformable plasmids imparting distinct antibiotic resistance traits to their Escherichia coli transformants. In rabbit ileal loop assays, Pv NBA2365 did not show any fluid accumulation (FA) in contrast with Vc IDH02365 that showed high FA. To the best of our knowledge, this is the first report of a highly drug resistant P. vermicola and additionally co-existence of multidrug resistant V. cholerae and P. vermicola. Both the microbes appeared to possess a wide array of mobile genetic elements for a large spectrum of antimicrobial agents, some of which are being used in the treatment of acute diarrhea.

References

Apr 1, 1991·International Journal of Systematic Bacteriology·P A EdenN R Pace
Oct 1, 1972·Journal of General Microbiology·J N CoetzeeR W Hedges
Dec 1, 1969·Journal of Bacteriology·J R Kennedy, S H Richardson
Jan 1, 1995·Clinical Microbiology Reviews·J B KaperM M Levine
Dec 5, 1998·Microbiology and Molecular Biology Reviews : MMBR·S M FaruqueJ J Mekalanos
Sep 28, 2001·The Journal of Infectious Diseases·T MurataT Honda
Oct 13, 2001·Advances in Space Research : the Official Journal of the Committee on Space Research (COSPAR)·V D Kern, F D Sack
Oct 1, 1953·The Journal of Pathology and Bacteriology·S N DE, D N CHATTERJE
Jun 23, 2004·Research in Microbiology·Vincent Burrus, Matthew K Waldor
Nov 24, 2004·Southern Medical Journal·Patrick R Krake, Neeraj Tandon
Sep 30, 2005·Journal of Medical Microbiology·Myonsun YohTakeshi Honda
Mar 4, 2006·International Journal of Systematic and Evolutionary Microbiology·Vishal S SomvanshiErko Stackebrandt
Jun 27, 2006·Ophthalmology·Aaleya F KoreishiCarol L Karp
Oct 30, 2007·Journal of Medical Microbiology·Sarah M Macleod, David J Stickler
Sep 25, 2008·Nature Clinical Practice. Gastroenterology & Hepatology·Udayakumar Navaneethan, Ralph A Giannella
May 12, 2009·International Journal of Antimicrobial Agents·Neha RajparaAshima Kushwaha Bhardwaj
Jun 24, 2009·BMC Research Notes·Avik Kumar MukherjeeSandipan Ganguly
Sep 3, 2010·Nature·Henry H LeeJames J Collins
Feb 23, 2012·Recent Patents on Anti-infective Drug Discovery·Ashima K Bhardwaj, Priyabrata Mohanty
Feb 12, 2013·Recent Patents on Anti-infective Drug Discovery·Ashima K BhardwajNeha Rajpara
Jul 16, 2014·Journal of Global Antimicrobial Resistance·Nuntra SuwantaratRobert A Bonomo

❮ Previous
Next ❯

Datasets Mentioned

BETA
KC709648
KC709651
KC709647
VC1786ICE
KC709650
KC709653
KC709649
KC709652
AB219451.1
HQ888851.1

Methods Mentioned

BETA
RAPD
PCR
electrophoresis
ICE

Software Mentioned

BLAST
ABIS Bacterial Identification

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.